The Cancer Genomics Consortium (CGC) was developed by and for clinical cytogeneticists, molecular geneticists, and molecular pathologists. The CGC is committed to providing high quality education and promoting best laboratory practices in clinical cancer genomics.
The Compendium of Cancer Genome Aberrations (CCGA) is a collaborative effort to document and describe chromosome and other genomic abnormalities in cancer structured based on current WHO classification.